Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$85.28 - $112.6 $50,656 - $66,884
-594 Reduced 53.37%
519 $56,000
Q1 2024

May 10, 2024

SELL
$59.21 - $92.9 $43,815 - $68,746
-740 Reduced 39.94%
1,113 $101,000
Q4 2023

Jan 31, 2024

SELL
$37.55 - $62.64 $4,355 - $7,266
-116 Reduced 5.89%
1,853 $116,000
Q3 2023

Nov 01, 2023

BUY
$43.4 - $62.52 $5,034 - $7,252
116 Added 6.26%
1,969 $87,000
Q2 2023

Jul 31, 2023

BUY
$47.08 - $55.16 $23,069 - $27,028
490 Added 35.95%
1,853 $90,000
Q1 2023

May 01, 2023

SELL
$36.57 - $58.29 $1.12 Million - $1.79 Million
-30,709 Reduced 95.75%
1,363 $75,000
Q4 2022

Jan 31, 2023

SELL
$34.17 - $47.91 $236,900 - $332,160
-6,933 Reduced 17.77%
32,072 $1.29 Million
Q3 2022

Nov 10, 2022

BUY
$36.93 - $56.68 $360,362 - $553,083
9,758 Added 33.36%
39,005 $1.71 Million
Q2 2022

Aug 12, 2022

BUY
$28.13 - $44.54 $9,479 - $15,009
337 Added 1.17%
29,247 $1.04 Million
Q1 2022

May 16, 2022

SELL
$30.32 - $91.33 $973,393 - $2.93 Million
-32,104 Reduced 52.62%
28,910 $1.18 Million
Q4 2021

Feb 11, 2022

BUY
$86.26 - $119.0 $99,371 - $137,088
1,152 Added 1.92%
61,014 $5.7 Million
Q3 2021

Nov 10, 2021

BUY
$100.17 - $126.36 $189,621 - $239,199
1,893 Added 3.27%
59,862 $6.67 Million
Q2 2021

Aug 12, 2021

SELL
$86.05 - $119.72 $641,588 - $892,632
-7,456 Reduced 11.4%
57,969 $6.58 Million
Q1 2021

May 17, 2021

BUY
$91.47 - $124.36 $2.67 Million - $3.63 Million
29,208 Added 80.65%
65,425 $6.64 Million
Q4 2020

Feb 16, 2021

SELL
$66.66 - $111.74 $455,954 - $764,301
-6,840 Reduced 15.89%
36,217 $3.6 Million
Q3 2020

Nov 13, 2020

BUY
$45.89 - $72.67 $473,355 - $749,591
10,315 Added 31.5%
43,057 $3.11 Million
Q2 2020

Aug 14, 2020

BUY
$26.36 - $49.86 $264,891 - $501,043
10,049 Added 44.28%
32,742 $1.63 Million
Q1 2020

May 15, 2020

BUY
$17.27 - $40.17 $391,908 - $911,577
22,693 New
22,693 $678,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Knights Of Columbus Asset Advisors LLC Portfolio

Follow Knights Of Columbus Asset Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.